Provided by Tiger Trade Technology Pte. Ltd.

LEPU BIO

3.915
-0.070-1.76%
Volume:4.30M
Turnover:16.95M
Market Cap:7.06B
PE:22.49
High:4.030
Open:4.000
Low:3.900
Close:3.985
52wk High:8.630
52wk Low:3.550
Shares:1.80B
HK Float Shares:1.80B
Volume Ratio:0.45
T/O Rate:0.24%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.174
ROE:24.24%
ROA:-0.07%
PB:4.27
PE(LYR):22.49
PS:6.09

Loading ...

Lepu Biopharma Interim Results: Product Sales More Than Double, Revenue Up 12%, Profit Slips to RMB24.85 Million

Bulletin Express
·
Yesterday

China's Lepu Biopharma H1 Revenue Rises 12.1% on Higher Drug Sales

Reuters
·
Yesterday

Lepu Biopharma H1 Revenue RMB 371.3 Million

THOMSON REUTERS
·
Yesterday

HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty

Stock News
·
Sep 11

LEPU Bio Shares Jump Over 5% in Afternoon Trading on Strong H1 Revenue Growth and Upcoming Full-Cycle BD Milestone

Stock News
·
Aug 27

Lepu Biopharma (SEHK:2157) Stock Grapples With Profit Quality Concerns

Simply Wall St.
·
Aug 21

Lepu Biopharma FY26 H1 Profit Falls 15.2% to RMB 24.8 Million; Revenue Rises 12.1% to RMB 522.4 Million

Reuters
·
Aug 19

LEPU BIO Sets 19 August 2026 Board Meeting to Approve H1 2026 Results and Assess Interim Dividend

Bulletin Express
·
Aug 07

Lepu Biopharma Sets Board Meeting to Review Interim Results, Consider Dividend

Reuters
·
Aug 07

LEPU BIO Maintains 1.80 Billion Issued Shares and Confirms Public Float Compliance for July 2026

Bulletin Express
·
Aug 03

Hong Kong Stock Movers: LEPU BIO Surges Nearly 4% After Positive Topline Results from Global Phase III CMG901 Trial

Stock News
·
Jul 28

Lepu Biopharma Reports Positive Top-Line Results from Global Phase III Trial of Cmg901 (azd0901)

Reuters
·
Jul 28

Lepu Biopharma Says Phase III CLARITY-Gastric01 Trial Meets Overall Survival Endpoint for Cmg901 in Late-line Gastric Cancer

Reuters
·
Jul 28

LEPU BIOPHARMA Names Ren Fangyuan Employee Representative Supervisor After Zhao Lixuan Resignation

Bulletin Express
·
Jul 15

LEPU BIO Announces New Employee Representative Supervisor Appointment

Stock News
·
Jul 15

Lepu Biopharma Names Ren Fangyuan Employee Representative Supervisor, Replacing Zhao Lixuan

Reuters
·
Jul 15

LEPU BIO Shares Surge Again, Gaining Over 7% on Promising Drug Candidate

Stock News
·
Jul 15

Lepu Biopharma (SEHK:2157) Rebound Puts Its Valuation Back In Focus

Simply Wall St.
·
Jul 08

LEPU BIO Posts Static Share Capital in June 2026, Confirms Sufficient Public Float

Bulletin Express
·
Jul 06

Hong Kong Innovative Drug Stocks Jump With HAIXI PHARMA and INNOCARE up 7%; KEYMED up 5%, REMEGEN up 4%

Tiger Newspress
·
Jul 06